ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GLMD Galmed Pharmaceuticals Ltd

0.4392
0.0509 (13.11%)
15 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -6.09M-3.73M-5.38M-2.45M-2M-1.87M-1.47M-2.15M
Pre Tax Income -6.14M-3.73M-5.35M-2.64M-1.83M-1.59M-1.47M-2.02M
Net Income -6.14M-3.73M-5.35M-2.64M-1.83M-1.59M-1.47M-2.02M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -6.09M-3.73M-5.38M-2.98M-2M-1.87M-1.47M-2.16M
EBITDA -6.08M-3.72M-5.37M-2.44M-1.99M-1.86M-1.46M-2.15M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 467k1.09M2.04M00000
Operating Income -16.88M-12.36M-10.72M-22.38M-30.21M-32.88M-17.65M-7.49M
Pre Tax Income -16.85M-12.3M-9.78M-20.46M-28.77M-32.47M-17.87M-6.91M
Net Income -16.95M-12.3M-9.86M-20.46M-28.77M-32.47M-17.87M-6.91M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.395-0.852-0.469-0.968-1.349-1.294-0.709-1.37
EBIT -16.85M-12.3M-10.76M-22.38M-30.21M-32.96M-18.18M-7.51M
EBITDA -16.71M-12.13M-10.33M-22.34M-30.17M-32.84M-17.62M-7.46M

Your Recent History

Delayed Upgrade Clock